0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query globaldata pharmsource cell therapy market opportunity cmos 2018 edition.Your search for "" gave back 1532977 results.
Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Genetic modification of humans via gene therapy is becoming a treatment option for diseases ranging from rare metabolic disorders to cancer. The “...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Lentivirus Particle market size was valued at USD 287.1 million in 2022 and is forecast to a readjusted size of USD 380.7 million by 2029...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Cell and gene supply chain solutions help mitigate distribution risks with features designed to improve product handling and unforeseen disruptions...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Primary cells undergo a finite number of population doublings and reach a state called replicative senescence after limited cell divisions. Cell...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The “Genetic Modification Therapies Clinical Applications Industry Forecast” looks at past sales and reviews total world Genetic Modification...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) - Drugs in Development, 2021 Summary Phenylalanine 4 Hydroxylase (Phe 4...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
According to our Publisher latest study, the global Genetic Modification Therapies Clinical Applications market size was valued at USD million in...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Plasminogen Activator Inhibitor 1 - Drugs In Development, 2021 Summary Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor...
Catalog:
Global Markets Direct
July 2021
Price: USD 3,500.00
The global Cas Nuclease market size was valued at USD 150.8 million in 2023 and is forecast to a readjusted size of USD 787 million by 2030 with a...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) Drugs in Development by Therapy Areas and...
Catalog:
Global Markets Direct
June 2022
Price: USD 3,500.00
Usher Syndrome - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Usher...
Catalog:
Global Markets Direct
November 2021
Price: USD 2,000.00
Genetic modification of humans via gene therapy is becoming a treatment option for diseases ranging from rare metabolic disorders to cancer...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
